Divalproex Sodium 250 mg & 500 mg (Sustained Release)

Get a Price/Quote

MOQ : 15-30 Boxes

Divalproex Sodium 250 mg & 500 mg (Sustained Release) Specification

Drug Type
Specific Drug

Ingredients
Alprazolam 0.25 mg & Fluoxetine 20 mg

Physical Form
Tablets

Function
Other

Recommended For
Epilepsy, Migraine, Mania

Dosage
Epilepsy: Initial 10-15 mg/kg/day in divided dose if necessary may increase by 5-10 mg/kg/week. Migraine: 500 mg once daily for 1 week, may increase to 1000 mg once daily. Mania: Initial: 25 mg/kg once daily, Max: 60 mg/kg/day

Suitable For
Women, Adults, Aged Person, Suitable For All, Children, Teenagers

Divalproex Sodium 250 mg & 500 mg (Sustained Release) Trade Information

Minimum Order Quantity
15-30 Boxes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Alu-Alu,10*10 Packing

Main Domestic Market
All India

Certifications
WHO-GMP

Divalproex Sodium 250 mg & 500 mg (Sustained Release) About

Divalproex Sodium 250 mg & 500 mg (Sustained Release) is a specific drug formulated as sustained-release tablets to cater to diverse needs, including epilepsy, migraine, and mania management. Recommended for children, teenagers, adults, women, and aged persons, it ensures suitability for all age groups. For epilepsy, the initial dosage is 10-15 mg/kg/day, adjustable by 5-10 mg/kg/week as needed. For migraine relief, a 500 mg dose once daily may be increased to 1000 mg, while for mania, the initial dosage is 25 mg/kg once daily, with a maximum limit of 60 mg/kg/day. Designed for precision and effectiveness, this pharmaceutical solution leverages Divalproex Sodium (250 mg & 500 mg) as its core ingredient. Its sustained-release formulation optimizes therapeutic consistency, providing effective treatment that aligns with professional medical guidelines.